Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07849842 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mangosteen Gel for Sunburn-Like Skin Redness Caused by Ultraviolet B Light

StatusCompleted
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase: Not applicable to Phase 2 Show 7 more changesShow less
    • Primary endpoint revised
    • Primary and study completion dates: Aug 23, 2022 to Nov 23, 2022
    • Interventions: Narrowband Ultraviolet B Irradiation (Radiation), Topical Garcinia mangostana Pericarp Extract Gel 10% (Drug), Topical Garcinia mangostana… to Narrowband Ultraviolet B Irradiation (Radiation), Topical Garcinia mangostana Pericarp Extract Gel 10% (Drug), Topical Garcinia mangostana…
    • Eligibility criteria expanded, about 16 words
    • Secondary endpoints expanded, about 19 words
    • Study description expanded, about 199 words
    • Study title expanded, about 4 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial was to learn whether a gel made from mangosteen (Garcinia mangostana) fruit rind helps sunburn-like skin redness fade faster when it is applied after the redness has already appeared. The trial was conducted in healthy adult women with Fitzpatrick skin phototypes IV-V. The main questions it aimed to answer were: * Does mangosteen pericarp extract gel reduce skin redness (measured as the chromameter a\* value) more than a placebo gel between Day 1 and Day 3? * Which concentration of the gel (2.5%, 5%, or 10%) works best, and is the gel well tolerated? Researchers compared three concentrations of mangosteen gel with a placebo gel and with untreated skin, all on the same person's back. Participants: * Had six small test areas marked on the upper back * Had five of these areas exposed to a measured dose of narrowband ultraviolet B light to cause mild redness, while one area was shielded * Had the assigned gels applied twice daily on Days 1 and 2, starting 24 hours after light exposure * Had skin color measured with a chromameter on Day 1 and Day 3, and were checked for skin reactions at each visit
Trial Details
NCT Number NCT07849842
Lead Sponsor Hasanuddin University
Conditions
(from sponsor)		 Narrowband Ultraviolet B-Induced Skin Erythema, Erythema, Sunburn, Erythema
Related terms Erythema, Sunburn
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov